Screen: 27
Hidekazu Tanaka, MD, PhD
Yamaguchi University Graduate School of Medicine
Ube, Yamaguchi
Univariate | Multivariate | ||||
HR (95% CI) | p value | HR (95% CI) | p value | ||
Pathology | SCLC vs. NSCLC | 0.970 (0.550–1.711) | 0.917 | ||
Age | <70 vs. =70 | 1.350 (0.846–2.154) | 0.208 | ||
PS | =2 vs. =1 | 1.627 (1.009–2.625) | 0.046 | 1.228 (0.7475–2.0170) | 0.417 |
BED | <40 vs. =40Gy | 1.174 (0.628–2.192) | 0.615 | ||
Irradiated site | bone vs. others | 1.337 (0.833–2.146) | 0.228 | ||
Other metastases | Yes vs. No | 1.253 (0.682–2.300) | 0.467 | ||
Chemotherapy after RT | Yes vs. No | 0.192 (0.099–0.373) | <0.001 | 0.5201 (0.3051–0.8867) | 0.016 |
MLR | Low vs. high | 0.320 (0.152–0.673) | 0.003 | 0.2820 (0.1316–0.6047) | 0.001 |